4 Healthcare Stock Stories Getting Traction Today
Eli Lilly & Co. (NYSE:LLY): Closing price $52.61
Lilly will depend upon the quality of a diversified product portfolio to help its sales forces grab a larger piece of the $22-billion domestic diabetes market, marking a difference in strategy to some of its competitors. President Enrique Conterno of Lilly Diabetes remarked in an interview that, “I don’t think the market is responsive today to putting more and more sales people focused on brands. We start with the patient and think of all the therapies we could have for him” instead of “trying to force a brand” on both diabetics and physicians.
Conterno continued that Lilly plans only “very limited expansion, wherever we may need it,” to its diabetes sales forces as it prepares to debut up to four new therapies by 2016.